1. Home
  2. RNA vs ROAD Comparison

RNA vs ROAD Comparison

Compare RNA & ROAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • ROAD
  • Stock Information
  • Founded
  • RNA 2012
  • ROAD 2001
  • Country
  • RNA United States
  • ROAD United States
  • Employees
  • RNA N/A
  • ROAD N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • ROAD Engineering & Construction
  • Sector
  • RNA Health Care
  • ROAD Industrials
  • Exchange
  • RNA Nasdaq
  • ROAD Nasdaq
  • Market Cap
  • RNA 3.4B
  • ROAD 3.9B
  • IPO Year
  • RNA 2020
  • ROAD 2018
  • Fundamental
  • Price
  • RNA $27.87
  • ROAD $95.75
  • Analyst Decision
  • RNA Strong Buy
  • ROAD Buy
  • Analyst Count
  • RNA 12
  • ROAD 4
  • Target Price
  • RNA $68.25
  • ROAD $91.00
  • AVG Volume (30 Days)
  • RNA 1.4M
  • ROAD 464.2K
  • Earning Date
  • RNA 05-08-2025
  • ROAD 05-09-2025
  • Dividend Yield
  • RNA N/A
  • ROAD N/A
  • EPS Growth
  • RNA N/A
  • ROAD N/A
  • EPS
  • RNA N/A
  • ROAD 1.13
  • Revenue
  • RNA $8,927,000.00
  • ROAD $2,189,187,000.00
  • Revenue This Year
  • RNA N/A
  • ROAD $51.05
  • Revenue Next Year
  • RNA $135.33
  • ROAD $11.65
  • P/E Ratio
  • RNA N/A
  • ROAD $84.52
  • Revenue Growth
  • RNA N/A
  • ROAD 31.49
  • 52 Week Low
  • RNA $21.51
  • ROAD $51.63
  • 52 Week High
  • RNA $56.00
  • ROAD $103.69
  • Technical
  • Relative Strength Index (RSI)
  • RNA 45.31
  • ROAD 73.66
  • Support Level
  • RNA $25.58
  • ROAD $88.88
  • Resistance Level
  • RNA $33.62
  • ROAD $91.84
  • Average True Range (ATR)
  • RNA 2.09
  • ROAD 3.62
  • MACD
  • RNA -0.29
  • ROAD 1.33
  • Stochastic Oscillator
  • RNA 28.53
  • ROAD 92.46

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

Share on Social Networks: